Generex Signs Letter of Intent with Kiromic to Merge with NuGenerex Immuno-Oncology Forming a Multi-Platform Clinical Stage Immunotherapy Company

Stock Information for Generex Biotechnology

Loading

Please wait while we load your information from QuoteMedia.